Focus Partners Wealth Purchases New Shares in Oscar Health, Inc. (NYSE:OSCR)

Focus Partners Wealth acquired a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 54,209 shares of the company's stock, valued at approximately $729,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. lifted its stake in Oscar Health by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company's stock valued at $255,333,000 after buying an additional 586,626 shares in the last quarter. Deerfield Management Company L.P. Series C lifted its stake in Oscar Health by 50.7% in the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock valued at $159,062,000 after buying an additional 3,983,325 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in Oscar Health by 348.7% in the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock valued at $139,246,000 after buying an additional 8,051,379 shares in the last quarter. Gilder Gagnon Howe & Co. LLC lifted its stake in Oscar Health by 51.4% in the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock valued at $85,154,000 after buying an additional 2,151,256 shares in the last quarter. Finally, BIT Capital GmbH lifted its stake in Oscar Health by 5,711.6% in the fourth quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock valued at $60,129,000 after buying an additional 4,396,872 shares in the last quarter. Institutional investors own 75.70% of the company's stock.

Insiders Place Their Bets

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company's stock in a transaction on Monday, May 12th. The shares were sold at an average price of $16.43, for a total transaction of $410,750.00. Following the sale, the director now directly owns 64,512 shares of the company's stock, valued at approximately $1,059,932.16. This represents a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 24.39% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on OSCR shares. Wells Fargo & Company lowered shares of Oscar Health from an "overweight" rating to an "equal weight" rating and cut their price target for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Wall Street Zen lowered shares of Oscar Health from a "buy" rating to a "hold" rating in a research note on Thursday. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $20.08.

Oscar Health Stock Down 1.6%

Shares of OSCR stock traded down $0.23 during trading on Friday, reaching $14.14. The company's stock had a trading volume of 7,545,626 shares, compared to its average volume of 4,311,386. The business has a fifty day moving average price of $13.66 and a 200-day moving average price of $14.58. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a market cap of $3.54 billion, a price-to-earnings ratio of -706.65 and a beta of 1.75. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, topping analysts' consensus estimates of $0.83 by $0.09. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The business had revenue of $3 billion for the quarter, compared to analyst estimates of $2.87 billion. During the same quarter in the previous year, the firm posted $0.62 earnings per share. The firm's revenue for the quarter was up 42.2% on a year-over-year basis. Analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.